Skip to main content

AMGEN INC

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three months endedSeptember 30,Nine months endedSeptember 30,
2025202420252024
Revenues:
Product sales$9,137$8,151$25,781$23,310
Other revenues4203521,1041,028
Total revenues9,5578,50326,88524,338
Operating expenses:
Cost of sales3,0823,3109,0619,746
Research and development1,9001,4505,1304,240
Selling, general and administrative1,7201,6255,0985,218
Other329711,236187
Total operating expenses7,0316,45620,52519,391
Operating income2,5262,0476,3604,947
Other income (expense):
Interest expense, net(685)(776)(2,102)(2,408)
Other income, net2,0801,8303,2041,288
Income before income taxes3,9213,1017,4623,827
Provision for income taxes7052711,084364
Net income$3,216$2,830$6,378$3,463
Earnings per share:
Basic$5.98$5.27$11.86$6.45
Diluted$5.93$5.22$11.77$6.40
Weighted-average shares used in calculation of earnings per share:
Basic538537538537
Diluted542542542541
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.